Benefit of specialized clinics for the treatment of patients with heart failure

Ghazaleh Gouya1, Alexandra Hammer, Marie Elhenicky

  • 1Department of Clinical Pharmacology, Medical University Vienna, Austria. ghazaleh.gouya@meduniwien.ac.at

Insights

Specialized heart failure clinics improve care for newly referred patients, optimizing medication and quality of life. Long-term patients showed no additional benefit, suggesting focused initial intervention is key for heart failure (HF) management.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Pharmacotherapy

Background:

  • Current guidelines advocate specialized outpatient units for heart failure (HF) patient care.
  • This study evaluates the benefit of specialized HF clinics for different patient referral timelines.

Purpose of the Study:

  • To determine if all heart failure patients achieve equivalent benefits in specialized clinics.
  • To compare outcomes for recently referred patients versus those in long-term care (>1 year).

Main Methods:

  • Observational cohort study with 474 heart failure patients.
  • Patients stratified into recently referred (130) and long-term care (344) groups.
  • Data collected at baseline and 12-month follow-up.

Main Results:

  • Recently referred patients showed significant pharmacotherapy enhancement (67%), NT-proBNP reduction, and improved quality of life.
  • Long-term care patients exhibited no significant changes in these parameters.
  • Hospitalization rates were higher in recently referred patients; all-cause mortality was similar between groups.

Conclusions:

  • Specialized HF clinics optimize pharmacotherapy and improve quality of life and NT-proBNP levels in patients referred within 12 months.
  • Maintenance therapy beyond this initial optimization period yields minimal additional benefit for chronic HF patients.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...